What specific opportunity in Germany is Moderna exploring, according to CEO Stephane Bancel?

Moderna is interested in investing in production facilities in Germany, specifically targeting plants that its German rival BioNTech plans to close. CEO Stephane Bancel stated that, if Moderna could establish the right partnership with the German government, acquiring or repurposing these existing BioNTech facilities would be 'an interesting option — compared with building a new one.'

Why does Moderna view BioNTech's planned facility closures as strategically advantageous?

Moderna views BioNTech's planned facility closures as an opportunity to enter or expand manufacturing capacity in Germany more efficiently — by leveraging existing infrastructure rather than undertaking the time, cost, and regulatory burden of constructing new facilities from scratch. As Bancel explained to Handelsblatt, such facilities would be 'an interesting option — compared with building a new one,' implying a preference for accelerated, lower-risk scale-up through acquisition or partnership.

Moderna Interested in Germany Production, Sees Opportunity in BioNTech Closures, Says CEO

ChemBrief

Moderna Interested in Germany Production, Sees Opportunity in BioNTech Closures, Says CEO — ChemBrief Topics

Moderna Interested in Germany Production, Sees Opportunity in BioNTech Closures, Says CEO

FAQ